down arrow

2seventy Bio, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals: Major
  • ISIN: US9013841070
USD
5.00
0.00 (0.00%)

May 14

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.000.00

52 Week

2.295.30
Valuation
Technical
Day's Volume

CASH

0

Shareholding (Mar 2025)

FII

12.94%

Held by 73 FIIs

DII

48.82%

Held by 36 DIIs

Promoter

9.73%

How big is 2seventy Bio, Inc.?

22-Jun-2025

As of May 14, 2seventy Bio, Inc. has a market capitalization of 257.94 million, classifying it as a Micro Cap company, with net sales of 48.37 million and a net profit of -4.09 million over the latest four quarters.

Market Cap: As of May 14, 2seventy Bio, Inc. has a market capitalization of 257.94 million, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 48.37 million and a net profit of -4.09 million.<BR><BR>Balance Sheet Snapshot: As of December 2024, the company has shareholder's funds of 210.81 million and total assets amounting to 479.51 million.

Read More

What does 2seventy Bio, Inc. do?

22-Jun-2025

2seventy Bio, Inc. is a micro-cap pharmaceutical company with recent net sales of $23 million and a market cap of $257.94 million. It has a P/E ratio of 77.00 and no dividend yield.

Overview: <BR>2seventy Bio, Inc. operates in the pharmaceuticals industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 23 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 257.94 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 77.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.72 <BR>Return on Equity: 1.57% <BR>Price to Book: 1.21 <BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold 2seventy Bio, Inc.?

22-Jun-2025
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a growth in Net Profit of NAN%, the company declared Very Positive results in Mar 25

  • OPERATING CASH FLOW(Y) Highest at USD -54.08 MM
  • ROCE(HY) Highest at -1.94%
  • PRE-TAX PROFIT(Q) At USD 0.54 has Grown at 104.55%
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals: Major

stock-summary
Market cap

USD 258 Million (Micro Cap)

stock-summary
P/E

77.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.72

stock-summary
Return on Equity

1.57%

stock-summary
Price to Book

1.21

Revenue and Profits:
Net Sales:
23 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
96.85%
0%
96.85%
6 Months
27.55%
0%
27.55%
1 Year
5.71%
0%
5.71%
2 Years
-56.22%
0%
-56.22%
3 Years
-58.05%
0%
-58.05%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

2seventy Bio, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.55%
EBIT Growth (5y)
21.92%
EBIT to Interest (avg)
-203.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.29
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0.39%
Valuation key factors
Factor
Value
P/E Ratio
77
Industry P/E
Price to Book Value
1.21
EV to EBIT
-1.76
EV to EBITDA
-1.98
EV to Capital Employed
1.73
EV to Sales
2.16
PEG Ratio
0.76
Dividend Yield
NA
ROCE (Latest)
-98.35%
ROE (Latest)
1.57%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 44 Schemes (28.51%)

Foreign Institutions

Held by 73 Foreign Institutions (12.94%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 689.66% vs -78.52% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 102.56% vs -96.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.90",
          "val2": "2.90",
          "chgp": "689.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "-21.40",
          "chgp": "96.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.20",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.50",
          "val2": "-19.50",
          "chgp": "102.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-107.40%",
          "val2": "-7,892.70%",
          "chgp": "778.53%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -62.25% vs 9.73% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 73.71% vs 14.40% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.90",
          "val2": "100.40",
          "chgp": "-62.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-98.40",
          "val2": "-206.40",
          "chgp": "52.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.90",
          "val2": "-20.90",
          "chgp": "52.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-57.20",
          "val2": "-217.60",
          "chgp": "73.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,787.50%",
          "val2": "-2,158.70%",
          "chgp": "-62.88%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
22.90
2.90
689.66%
Operating Profit (PBDIT) excl Other Income
-0.80
-21.40
96.26%
Interest
0.00
0.00
Exceptional Items
-0.10
-0.20
50.00%
Consolidate Net Profit
0.50
-19.50
102.56%
Operating Profit Margin (Excl OI)
-107.40%
-7,892.70%
778.53%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is 689.66% vs -78.52% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 102.56% vs -96.97% in Dec 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
37.90
100.40
-62.25%
Operating Profit (PBDIT) excl Other Income
-98.40
-206.40
52.33%
Interest
0.00
0.00
Exceptional Items
-9.90
-20.90
52.63%
Consolidate Net Profit
-57.20
-217.60
73.71%
Operating Profit Margin (Excl OI)
-2,787.50%
-2,158.70%
-62.88%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -62.25% vs 9.73% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 73.71% vs 14.40% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About 2seventy Bio, Inc. stock-summary
stock-summary
2seventy Bio, Inc.
Pharmaceuticals: Major
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."